Loading...

Purified anti-mouse CD274 (B7-H1, PD-L1) Antibody

Pricing & Availability
Clone
10F.9G2 (See other available formats)
Regulatory Status
RUO
Other Names
B7-H1, PD-L1
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
10Fdot9G2_Pure_081908.jpg
C57/B6 mouse splenocytes were stained with purified anti-CD274 (clone 10F.9G2) (pink line) or purified rat IgG2b, κ isotype control (green line), followed by biotinylated anti-rat IgG and Sav-PE
  • 10Fdot9G2_Pure_081908.jpg
    C57/B6 mouse splenocytes were stained with purified anti-CD274 (clone 10F.9G2) (pink line) or purified rat IgG2b, κ isotype control (green line), followed by biotinylated anti-rat IgG and Sav-PE
  • 10Fdot9G2_Pure_CD274_2_102518
    Fresh, frozen mouse spleen was stained with purified CD274 clone 10F.9G2 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with TCR FITC (greeb). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
124301 50 µg 44€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
124302 500 µg 113€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activated endothelial cells, and monocytes. B7-H1 is one of the ligands of PD-1. The interaction of B7-H1 with PD-1 plays an important role in the inhibition of T cell responses. Other studies have shown that B7-H1 is able to costimulate T cell growth and cytokine production. CD274 is involved in costimulation essential for T cell proliferation and production of IL-10 and IFN-γ, in an IL-2-dependent and a PD-1-independent manner. Its interaction with PD-1 inhibits T cell proliferation and cytokine production.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
Block - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunofluorescence4, blocking6,7,8,9, and immunohistochemistry of acetone-fixed frozen sections4, 11. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 124303). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 124318) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Maier H, et al. 2007. J. Immunol. 178:2714.
  2. Meng Q, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:4444. PubMed
  3. Scarlett UK, et al. 2012. J Exp Med. 209:495. PubMed
  4. Grabie N, et al. 2007. Circulation 116:2062. (IF, IHC)
  5. Paterson AM, et al. 2011. J. Immunol. 187:1097.
  6. Channappanavar R, et al. 2012. PLoS One 7:e39757. (Block)
  7. Schreiber HA, et al. 2010. PLoS One 5:e11453. (Block) PubMed
  8. Muthumani K, et al. 2011. J. Immunol. 187:2932. (Block) PubMed
  9. Cripps JG, et al. 2010. Hepatology 52:1350. (Block) PubMed
  10. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  11. Riella LV, et al. 2011. Am. J. Transplant 11:832-40. (IHC)
  12. Lei GS, et al. 2015. Infect Immun. 83:572. PubMed
Product Citations
  1. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  2. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  3. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  4. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  5. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  6. Sun Y, et al. 2022. Mol Ther Oncolytics. 26:105. PubMed
  7. Peymanfar Y, et al. 2023. Int J Mol Sci. 24:. PubMed
  8. Dieterich LC, et al. 2017. Front Immunol. 0.379166667. PubMed
  9. Iwai T, et al. 2021. Mol Cancer Ther. 20:2519. PubMed
  10. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  11. Herold M, et al. 2015. J Immunol. 195: 3584 - 3595. PubMed
  12. Wang G, et al. 2020. Nat Commun. 11:1395. PubMed
  13. Schofield DJ, et al. 2021. MAbs. 13:1857100. PubMed
  14. Tan Z, et al. 2020. Mol Ther Oncolytics. 16:302. PubMed
  15. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  16. Lei G, et al. 2015. Infect Immun . 83:572. PubMed
  17. Singh M, et al. 2017. Nat Commun. 8:1447. PubMed
  18. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  19. Meng Q, et al. 2006. Invest Ophthalmol Vis Sci. 47:4444. PubMed
  20. Tanaka Y, et al. 2020. Sci Rep. 10:17284. PubMed
  21. Kong F, et al. 2021. Front Immunol. 12:670646. PubMed
  22. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  23. Yahata T, et al. 2019. Cancer Sci. 110:1279. PubMed
  24. Speranza MC, et al. 2018. Neuro Oncol. 20:225. PubMed
  25. Muhammad F, et al. 2020. J Autoimmun. 111:102441. PubMed
  26. Sano Y, et al. 2021. Mol Cancer Res. 19:507. PubMed
  27. Zhao T, et al. 2022. JCI Insight. 7:. PubMed
  28. Scarlett U, et al. 2012. J Exp Med. 209:425. PubMed
  29. Mao W, et al. 2019. J Immunother Cancer. 0.484027778. PubMed
  30. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  31. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  32. Lin A, et al. 2022. Bioeng Transl Med. 7:e10314. PubMed
  33. Bassi &, et al. 2012. Diabetes. 61:2534. PubMed
  34. Iida Y, et al. 2020. J Immunother Cancer. 8:. PubMed
  35. Li Z, et al. 2022. Transl Cancer Res. 11:3698. PubMed
  36. Hirose T, et al. 2017. PLoS One. 12(6):e0178765. PubMed
  37. Knier B, et al. 2018. Nat Immunol. 1.722916667. PubMed
  38. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  39. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
RRID
AB_961228 (BioLegend Cat. No. 124301)
AB_961228 (BioLegend Cat. No. 124302)

Antigen Details

Structure
40 kD type I transmembrane protein member of B7 family within the immunoglobulin receptor superfamily
Distribution

T cells, B cells, NK cells, dendritic cells, IFN-γ activated endothelial cells, and monocytes

Ligand/Receptor
PD-1 (PDCD1)
Cell Type
B cells, Dendritic cells, Endothelial cells, Monocytes, NK cells, T cells
Biology Area
Cancer Biomarkers, Costimulatory Molecules, Immunology
Molecular Family
Adhesion Molecules, CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Sharpe A, et al. 2007. Nat. Immunol. 8:239.
2. Dong H, et al. 1999. Nat. Med. 5:1365.
3. Freeman G, et al. 2000. J. Exp. Med. 192:1027.

Gene ID
60533 View all products for this Gene ID
UniProt
View information about CD274 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 01.08.2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account